Cite
HARVARD Citation
Madrid-Paredes, A. et al. (n.d.). ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients. Pharmacological research. pp. 111-118. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Madrid-Paredes, A. et al. (n.d.). ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients. Pharmacological research. pp. 111-118. [Online].